Which has the lower trailing P/E, ABT or TMO?

ABT has the lower trailing P/E: ABT trades at 32.78 and TMO at 32.80. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ABT or TMO?

Over the past five years, TMO grew revenue faster — ABT at a 2.98% CAGR versus TMO at 5.00%.

Does ABT or TMO pay a bigger dividend?

ABT yields 2.40% and TMO yields 0.30% based on trailing dividends and the latest price.

Is ABT or TMO more profitable?

TMO runs the higher net margin — ABT at 11.65% versus TMO at 15.06%.

How have ABT and TMO total returns compared?

Over the past 10 years, ABT delivered 11.77% and TMO delivered 15.81% annualized total return. Past performance doesn't predict future results.

Abbott Laboratories (ABT) vs Thermo Fisher Scientific Inc. (TMO)

A side-by-side comparison of Abbott Laboratories and Thermo Fisher Scientific Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 10, 2026. Differences are shown without an overall score or investment verdict.

ABT

Abbott Laboratories

$176.43B

$101.96HealthcareDelayed quote: Sep 11, 2026, 3:59 PM EDT

TMO

Thermo Fisher Scientific Inc.

$226.62B

$609.82HealthcareDelayed quote: Sep 11, 2026, 4:00 PM EDT

Total return — ABT vs TMO

growth of $100 · dividends reinvested · last 10y

ABT +212.0% (+12.1%/yr)TMO +314.9% (+15.3%/yr)TMO compounded faster over this window

ABT TMO

ABT vs TMO: by the numbers

•TMO is the larger company ($226.62B vs $176.43B market cap).
•TMO converts more revenue to profit (15.06% vs 11.65% net margin).
•TMO grew revenue faster over the past five years (5.00% vs 2.98% CAGR).
•ABT pays the higher dividend yield (2.40% vs 0.30%).

Metrics side by side

Valuation

Metric	ABT	TMO
P/E ratio	32.78	32.80
Forward P/E	18.48	24.29
P/S ratio	3.79	4.89
P/B ratio	3.45	4.30
EV / EBITDA	18.73	25.25
FCF yield	4.49%	3.23%

Profitability

Metric	ABT	TMO
Gross margin	56.80%	40.37%
Operating margin	17.03%	17.69%
Net margin	11.65%	15.06%
ROE	10.61%	13.25%
ROIC	6.07%	7.44%

Dividends

Metric	ABT	TMO
Dividend yield	2.40%	0.30%
Payout ratio	79.74%	9.68%

Growth (annualized)

Metric	ABT	TMO
Revenue CAGR (5Y)	2.98%	5.00%
EPS CAGR (5Y)	8.22%	1.99%
FCF CAGR (5Y)	0.18%	-1.83%
Total return CAGR (5Y)	-2.42%	1.55%

Frequently asked

Which has the lower trailing P/E, ABT or TMO?: ABT has the lower trailing P/E: ABT trades at 32.78 and TMO at 32.80. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ABT or TMO?: Over the past five years, TMO grew revenue faster — ABT at a 2.98% CAGR versus TMO at 5.00%.
Does ABT or TMO pay a bigger dividend?: ABT yields 2.40% and TMO yields 0.30% based on trailing dividends and the latest price.
Is ABT or TMO more profitable?: TMO runs the higher net margin — ABT at 11.65% versus TMO at 15.06%.
How have ABT and TMO total returns compared?: Over the past 10 years, ABT delivered 11.77% and TMO delivered 15.81% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ABT analysis Full TMO analysis Interactive comparison tool

Dig into the metrics

Abbott Laboratories P/E ratio Thermo Fisher Scientific P/E ratio Abbott Laboratories dividend yield Thermo Fisher Scientific dividend yield Abbott Laboratories ROE Thermo Fisher Scientific ROE Abbott Laboratories operating margin Thermo Fisher Scientific operating margin Abbott Laboratories revenue growth Thermo Fisher Scientific revenue growth Abbott Laboratories free cash flow Thermo Fisher Scientific free cash flow

Abbott Laboratories & Thermo Fisher Scientific appear in these rankings

Highest Dividend Yield Stocks 25+ Year Dividend Growers Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 10, 2026.